P A Jones Selected Research

P A Jones Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 05/2000
5	Craniocerebral Trauma (Head Injury) 01/2008 - 01/2005
3	Urinary Bladder Neoplasms (Bladder Cancer) 08/2001 - 05/2000
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2000
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2009 - 02/2003
2	Phototoxic Dermatitis (Phototoxicity) 10/2003 - 08/2003
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2001 - 05/2000
2	Colorectal Neoplasms (Colorectal Cancer) 10/2001 - 02/2000
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Obesity 01/2021
1	Insulin Resistance 01/2018
1	Birth Weight (Birth Weights) 01/2018
1	Epilepsy (Aura) 10/2015
1	Partial Epilepsies (Epilepsy, Partial) 10/2015
1	Normal Pressure Hydrocephalus 07/2013
1	Cryptorchidism (Undescended Testes) 10/2011
1	Critical Illness (Critically Ill) 01/2009
1	Hypoxia (Hypoxemia) 01/2008
1	Tachycardia (Tachyarrhythmias) 01/2008
1	Hypertension (High Blood Pressure) 01/2008
1	Fever (Fevers) 01/2008
1	Bradycardia 01/2008
1	Breast Neoplasms (Breast Cancer) 06/2005
1	Substance-Related Disorders (Drug Abuse) 03/2005
1	Photoallergic Dermatitis (Photoallergy) 08/2003
1	Corneal Opacity 11/2001
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2001
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2001
1	Stroke (Strokes) 05/2001
1	Body Weight (Weight, Body) 04/2001
1	Genomic Instability 03/2000

Drug/Important Bio-Agent (IBA)

6	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2009 - 01/2005
6	DNA (Deoxyribonucleic Acid)IBA 10/2001 - 02/2000
3	Neutral RedIBA 10/2003 - 11/2001
3	NucleotidesIBA 10/2001 - 05/2000
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	pyrimidin-2-one beta-ribofuranosideIBA 03/2017 - 12/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2001 - 10/2001
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2001 - 05/2000
2	Epidermal Growth Factor (EGF)IBA 09/2000 - 05/2000
2	FollistatinIBA 09/2000 - 05/2000
2	Proteins (Proteins, Gene)FDA Link 09/2000 - 05/2000
2	Messenger RNA (mRNA)IBA 05/2000 - 05/2000
2	MethyltransferasesIBA 05/2000 - 03/2000
1	HDL LipoproteinsIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	AndrogensIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2015
1	Antidepressive Agents (Antidepressants)IBA 10/2015
1	Ion Channels (Ion Channel)IBA 10/2015
1	LigandsIBA 10/2015
1	N-Methylaspartate (NMDA)IBA 10/2015
1	Amyloid (Amyloid Fibrils)IBA 07/2013
1	flutemetamolIBA 07/2013
1	ApolipoproteinsIBA 01/2009
1	Apolipoproteins E (ApoE)IBA 01/2009
1	A-factor (Streptomyces)IBA 03/2005
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2005
1	Human Serum Albumin FDA LinkGeneric 08/2003
1	ChromatinIBA 11/2001
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 11/2001
1	Histones (Histone)IBA 11/2001
1	Carrier Proteins (Binding Protein)IBA 11/2001
1	Fluorescein (Funduscein)FDA LinkGeneric 11/2001
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2001
1	Endothelin Receptors (Endothelin Receptor)IBA 04/2001
1	SolutionsIBA 04/2001
1	A-Form DNA (A-DNA)IBA 09/2000
1	Tumor Biomarkers (Tumor Markers)IBA 05/2000
1	Monoclonal AntibodiesIBA 05/2000
1	Retinoblastoma ProteinIBA 05/2000
1	hydrogen sulfite (bisulfite)IBA 05/2000
1	Biological ProductsIBA 05/2000

Therapy/Procedure

3	Therapeutics 01/2021 - 12/2004
3	Critical Care (Surgical Intensive Care) 01/2009 - 02/2003
1	Orchiopexy 10/2011
1	Radiotherapy 06/2005
1	Surgical Decompression 01/2005
1	Resuscitation 04/2001